News >

Expert Encourages Widespread Use of ERAS in Ovarian Cancer

Caroline Seymour
Published: Wednesday, May 09, 2018

Snehal Bhoola, MD

Snehal Bhoola, MD
Protocols for enhanced recovery after surgery (ERAS) across gynecologic malignancies are reflective of shorter hospital stays and quicker recoveries. The use of this approach has changed patient expectations for the better, says Snehal Bhoola, MD, who noted that ERAS is associated with better patient satisfaction scores.

State of the Science Summit™ on Ovarian Cancer, Bhoola, an assistant professor at Mercer University School of Medicine, and an associate professor at the University of Arizona, Arizona Oncology, discussed the implementation of ERAS in ovarian cancer.

OncLive: How has ERAS entered the landscape of ovarian cancer?

Bhoola: I’ve been an advocate of ERAS for some time. My hope for the discussion [at the meeting was] to demonstrate that we should all be using the ERAS protocols. There have been several retrospective studies, meta-analyses, and randomized trials that have looked at patients prospectively undergoing ERAS protocols.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Community Practice Connections™: Advances in Ovarian Cancer: Evolving Applications for PARP Inhibitors, Immunotherapy & Beyond!Aug 30, 20201.5
Publication Bottom Border
Border Publication